Raphaël Colle

1.0k total citations
22 papers, 363 citations indexed

About

Raphaël Colle is a scholar working on Oncology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Raphaël Colle has authored 22 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Pathology and Forensic Medicine and 4 papers in Epidemiology. Recurrent topics in Raphaël Colle's work include Genetic factors in colorectal cancer (16 papers), Colorectal Cancer Treatments and Studies (15 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Raphaël Colle is often cited by papers focused on Genetic factors in colorectal cancer (16 papers), Colorectal Cancer Treatments and Studies (15 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Raphaël Colle collaborates with scholars based in France, United States and Spain. Raphaël Colle's co-authors include Romain Cohen, Thierry André, Alex Duval, Magali Svrcek, Benoı̂t Rousseau, Joana Vidal, Luis A. Diaz, T. Pudlarz, Yann Parc and Jean-François Delattre and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Raphaël Colle

21 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raphaël Colle France	10	283	185	84	72	72	22	363
Van K. Morris United States	7	257 0.9×	174 0.9×	78 0.9×	40 0.6×	55 0.8×	29	349
Rossana Intini Italy	9	233 0.8×	69 0.4×	82 1.0×	55 0.8×	63 0.9×	29	307
Sabina Murgioni Italy	11	214 0.8×	105 0.6×	145 1.7×	85 1.2×	76 1.1×	38	361
Qiaoqi Sui China	11	215 0.8×	78 0.4×	63 0.8×	86 1.2×	52 0.7×	21	288
Hester C. van Wyk United Kingdom	10	287 1.0×	91 0.5×	88 1.0×	81 1.1×	56 0.8×	16	375
Corey Lipchik United States	5	413 1.5×	295 1.6×	89 1.1×	88 1.2×	105 1.5×	12	512
Seung Tae Kim South Korea	9	186 0.7×	68 0.4×	169 2.0×	89 1.2×	62 0.9×	16	322
Chenghao Yi China	9	216 0.8×	133 0.7×	64 0.8×	91 1.3×	125 1.7×	16	362
Hiromichi Shirasu Japan	10	232 0.8×	119 0.6×	168 2.0×	96 1.3×	143 2.0×	32	395
T.W. Kim South Korea	8	226 0.8×	60 0.3×	93 1.1×	76 1.1×	38 0.5×	26	264

Countries citing papers authored by Raphaël Colle

Since Specialization

Citations

This map shows the geographic impact of Raphaël Colle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaël Colle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaël Colle more than expected).

Fields of papers citing papers by Raphaël Colle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphaël Colle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaël Colle. The network helps show where Raphaël Colle may publish in the future.

Co-authorship network of co-authors of Raphaël Colle

This figure shows the co-authorship network connecting the top 25 collaborators of Raphaël Colle. A scholar is included among the top collaborators of Raphaël Colle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphaël Colle. Raphaël Colle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lefèvre, Jérémie H., Olivier Dubreuil, Raphaël Colle, et al.. (2025). Neoadjuvant pembrolizumab with a watch‑and‑wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 – PRODIGE 84 phase II trial (PREMICES). Digestive and Liver Disease. 58(1). 51–55.

Henríquez, Soledad, Pierre Charles, Raphaël Colle, et al.. (2025). Cardiovascular safety of a standardized outpatient triage and diagnostic approach for suspected cardiovascular immune-related adverse events of immune checkpoint inhibitors. Archives of cardiovascular diseases. 118(12). 671–680. 2 indexed citations

Colle, Raphaël, et al.. (2024). Age-related outcomes in MSI/dMMR gastrointestinal cancers treated by immune checkpoint inhibitors and toxicity’s impact on efficacy: an immunoMSI cohort study. SHILAP Revista de lepidopterología. 4. 100047–100047. 1 indexed citations

Svrcek, Magali, Anne Cayre, Raphaël Colle, et al.. (2024). High prevalence of NTRK fusions in sporadic dMMR/MSI mCRC RAS/RAF wild-type: an opportunity for a post-immune checkpoint inhibitors progression rescue strategy. SHILAP Revista de lepidopterología. 5. 100084–100084. 2 indexed citations

Couturier, Jeanne, et al.. (2023). Investigation of a Mycobacterium fortuitum catheter-related bloodstream infection in an oncology unit. Infection Control and Hospital Epidemiology. 44(8). 1342–1344. 1 indexed citations

Colle, Raphaël, Sara Lonardi, Marine Cachanado, et al.. (2023). Impact of Lynch syndrome, BRAF^V600E, and RAS mutations on outcomes in MSI/dMMR metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI): Analysis of combined international cohorts.. Journal of Clinical Oncology. 41(4_suppl). 171–171. 3 indexed citations

Colle, Raphaël, Sara Lonardi, Marine Cachanado, et al.. (2023). BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors. The Oncologist. 28(9). 771–779. 19 indexed citations

Colle, Raphaël, et al.. (2022). Réponse histologique complète d’un cancer colique métastatique de phénotype MisMatch Repair déficient/MicroSatellite Instable après immunothérapie : à propos d’un cas. Annales de Pathologie. 42(2). 172–176. 1 indexed citations

Cohen, Romain, Sara Lonardi, Francesca Corti, et al.. (2022). Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer. European Journal of Cancer. 172. 171–181. 11 indexed citations

10.

Svrcek, Magali, Raphaël Colle, Anne Cayre, et al.. (2021). 444P Prevalence of NTRK1/2/3 fusions in dMMR/MSI metastatic colorectal cancer. Annals of Oncology. 32. S556–S556. 1 indexed citations

11.

Cohen, Romain, Raphaël Colle, T. Pudlarz, et al.. (2021). Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency. Cancers. 13(5). 1149–1149. 32 indexed citations

12.

Cohen, Romain, Vincent Jonchère, Christelle de la Fouchardière, et al.. (2021). Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancer. Journal for ImmunoTherapy of Cancer. 9(2). e001903–e001903. 18 indexed citations

13.

Colle, Raphaël, Marine Cachanado, Alexandra Rousseau, et al.. (2021). Parameters associated with outcomes in pretreated MSI/dMMR metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI): Subgroup analysis of a prospective cohort.. Journal of Clinical Oncology. 39(15_suppl). 3580–3580. 1 indexed citations

14.

Lièvre, Astrid, Anthony Turpin, Isabelle Laure Ray-Coquard, et al.. (2020). 1673MO The GCO-002 CACOVID-19 cohort: A French nationwide multicenter study of COVID-19 infected cancer patients and consequences on cancer management. Annals of Oncology. 31. S993–S993. 1 indexed citations

15.

Colle, Raphaël, Romain Cohen, Anna Pellat, et al.. (2020). Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer. European Journal of Cancer. 144. 9–16. 37 indexed citations

16.

Ludford, Kaysia, Romain Cohen, Magali Svrcek, et al.. (2020). Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer. JNCI Journal of the National Cancer Institute. 113(2). 208–211. 42 indexed citations

17.

Cohen, Romain, T. Pudlarz, Jean-François Delattre, Raphaël Colle, & Thierry André. (2020). Molecular Targets for the Treatment of Metastatic Colorectal Cancer. Cancers. 12(9). 2350–2350. 30 indexed citations

18.

Cohen, Romain, Benoı̂t Rousseau, Joana Vidal, et al.. (2019). Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond. Targeted Oncology. 15(1). 11–24. 73 indexed citations

19.

Colle, Raphaël & Romain Cohen. (2018). Épidémiologie des tumeurs MSI : fréquence des tumeurs MSI en fonction de la localisation du cancer et de son stade. Bulletin du Cancer. 106(2). 114–118. 7 indexed citations

20.

Colle, Raphaël, Romain Cohen, Alex Duval, et al.. (2016). Immunotherapy and patients treated for cancer with microsatellite instability. Bulletin du Cancer. 104(1). 42–51. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact